AAAAAA
Results: 1-25/59
Authors:
CASELITZ M
LINK H
HEIN R
MASCHEK H
BOKER K
POLIWODA H
MANNS MP
Citation: M. Caselitz et al., HEPATITIS-B ASSOCIATED LIVER-FAILURE FOLLOWING BONE-MARROW TRANSPLANTATION, Journal of hepatology, 27(3), 1997, pp. 572-577
Authors:
DECKERT M
FRANZKE A
BUER J
PROBST M
DUENSING S
LOPEZHAENNINEN E
KIRCHNER H
POLIWODA H
ATZPODIEN J
Citation: M. Deckert et al., LINOMIDE AND INTERLEUKIN-2 IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 11(5), 1996, pp. 319-324
Authors:
DUENSING S
VANDENBERGDERUITER E
STORKEL S
KIRCHNER H
HANNINEN EL
BUER J
POLIWODA H
ATZPODIEN J
Citation: S. Duensing et al., CYTOGENETIC STUDIES IN RENAL-CELL CARCINOMA PATIENTS RECEIVING LOW-DOSE RECOMBINANT INTERLEUKIN-2-BASED IMMUNOTHERAPY, Tumor biology, 17(1), 1996, pp. 27-33
TECHNICAL AND SAFETY ASPECTS OF BLOOD AND MARROW TRANSPLANTATION USING G-CSF MOBILIZED FAMILY DONORS
Authors:
KADAR JG
ARSENIEV L
SCHNITGER K
SUDMEIER I
ZAKI M
BATTMER K
JACOBS R
DIEDRICH H
POLIWODA H
STANGEL W
LINK H
Citation: Jg. Kadar et al., TECHNICAL AND SAFETY ASPECTS OF BLOOD AND MARROW TRANSPLANTATION USING G-CSF MOBILIZED FAMILY DONORS, Transfusion science, 17(4), 1996, pp. 611-618
Authors:
LINK H
DIEDRICH H
ARSENIEV L
STOLL M
EBELL W
FREUND M
TISCHLER J
CASPER J
HUBNER G
SCHOFFSKI P
DIEHL S
GOES A
JACOBS R
KADAR J
STANGEL W
MULLER R
RITTMANN KL
WILDFANG I
BUCSKY P
BETTONI C
SCHMIDT RE
RIEHM H
POLIWODA H
Citation: H. Link et al., 10 YEARS TRANSPLANTATION OF BONE-MARROW A ND OF HEMATOPOIETIC STEM-CELLS AT THE MEDICAL-SCHOOL HANOVER, Medizinische Klinik, 91, 1996, pp. 3-17
Authors:
FREUND M
HEUSSNER P
HILD F
NOWAK R
GROTEMETKE A
DIEDRICH H
KOCH O
OTREMBA B
VONWUSSOW P
KLEINE HD
MERAN J
LINK H
HINRICHS HF
BALLEISEN L
FONATSCH C
POLIWODA H
Citation: M. Freund et al., TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA WITH INTERFERON-ALPHA - A DECADE OF EXPERIENCE, Medizinische Klinik, 91, 1996, pp. 18
Authors:
HUBNER G
LINK H
SCHONROCKNABULSI P
WANDT H
GRAMATZKI M
LOFFLER B
FACKLERSCHWALBE I
QUEISSER W
BRACK N
GEER T
RAAB M
OHL S
SCHNEIDER B
SCHNEIDER C
FREUND M
POLIWODA H
EHNINGER G
Citation: G. Hubner et al., INTENSIVE POSTREMISSION THERAPY IN ACUTE MYELOID-LEUKEMIA - RESULTS OF A PROSPECTIVE COMPARATIVE TRIAL, Medizinische Klinik, 91, 1996, pp. 26-32
Authors:
ATZPODIEN J
KIRCHNER H
POLIWODA H
Citation: J. Atzpodien et al., INTERLEUKIN-2 BASED OUTPATIENT THERAPY OF ADVANCED RENAL CALL CARCINOMA, Medizinische Klinik, 91, 1996, pp. 38-43
Authors:
KIRCHNER HH
ATZPODIEN J
POLIWODA H
Citation: Hh. Kirchner et al., CHEMOIMMUNOTHERAPY OF ADVANCED MALIGNANT- MELANOMA, Medizinische Klinik, 91, 1996, pp. 44-49
Authors:
LINK H
ARSENIEV L
BAHRE O
KADAR JG
DIEDRICH H
POLIWODA H
Citation: H. Link et al., TRANSPLANTATION OF ALLOGENEIC CD34(-CELLS() BLOOD), Blood, 87(11), 1996, pp. 4903-4909
Authors:
BUER J
HILSE R
DALLMANN I
GROSSE J
KIRCHNER H
ZORN U
HANNINEN EL
FRANZKE A
DUENSING S
POLIWODA H
ATZPODIEN J
Citation: J. Buer et al., LYMPHOCYTE-CONDITIONED MEDIUM IN COMBINATION WITH INTERLEUKIN-2 EFFECTIVELY INDUCES ANTITUMOR AUTOIMMUNITY BY ADOPTIVE TRANSFER OF SHORT ACTIVATED KILLER (SHAK) CELLS, Cytokines and molecular therapy, 1(1), 1995, pp. 39-46
Authors:
HANNINEN EL
POLIWODA H
ATZPODIEN J
Citation: El. Hanninen et al., INTERFERON-ALPHA 5-FLUOROURACIL - A NOVEL OUTPATIENT CHEMO IMMUNOTHERAPY FOR PROGRESSIVE METASTATIC RENAL-CELL CARCINOMA/, Cancer biotherapy, 10(1), 1995, pp. 21-24
Authors:
BOKEMEYER C
KUCZYK MA
FICHNA B
JONAS U
POLIWODA H
SCHMOLL HJ
Citation: C. Bokemeyer et al., LATE RELAPSE OF TESTICULAR CANCER PRESENTING AS DIFFERENTIATED TERATOMA - REPORT OF A CASE AND DISCUSSION OF THE CLINICAL IMPLICATIONS, Oncology Reports, 2(4), 1995, pp. 615-618
Authors:
BOKEMEYER C
LUDWIG E
REILE D
HARSTRICK A
POLIWODA H
SCHMOLL HJ
Citation: C. Bokemeyer et al., ANTITUMOR-ACTIVITY AND TOXICITY OF CONTINUOUS-INFUSION VERSUS BOLUS ADMINISTRATION OF BLEOMYCIN IN 2 HETEROTRANSPLANTED HUMAN TESTICULAR CANCER CELL-LINES, Oncology Reports, 2(1), 1995, pp. 161-165
Authors:
ATZPODIEN J
HANNINEN EL
KIRCHNER H
FRANZKE A
KORFER AK
VOLKENANDT M
DUENSING S
SCHOMBURG A
CHAITCHIK S
POLIWODA H
Citation: J. Atzpodien et al., CHEMOIMMUNOTHERAPY OF ADVANCED MALIGNANT-MELANOMA - SEQUENTIAL ADMINISTRATION OF SUBCUTANEOUS INTERLEUKIN-2 AND INTERFERON-ALPHA AFTER INTRAVENOUS DACARBAZINE AND CARBOPLATIN OR INTRAVENOUS DACARBAZINE, CISPLATIN, CARMUSTINE AND TAMOXIFEN, European journal of cancer, 31A(6), 1995, pp. 876-881
Authors:
ATZPODIEN J
HANNINEN EL
KIRCHNER H
BODENSTEIN H
PFREUNDSCHUH M
REBMANN U
METZNER B
ILLIGER HJ
JAKSE G
NIESEL T
SCHOLZ HJ
WILHELM S
PIELMEIER T
ZAKRZEWSKI G
BLUM G
BEIER J
MULLER GW
DUENSING S
ANTON P
ALLHOFF E
JONAS U
POLIWODA H
Citation: J. Atzpodien et al., MULTIINSTITUTIONAL HOME-THERAPY TRIAL OF RECOMBINANT HUMAN INTERLEUKIN-2 AND INTERFERON ALFA-2 IN PROGRESSIVE METASTATIC RENAL-CELL CARCINOMA, Journal of clinical oncology, 13(2), 1995, pp. 497-501
Authors:
ATZPODIEN J
KIRCHNER H
DUENSING S
HANNINEN EL
FRANZKE A
BUER J
PROBST M
ANTON P
POLIWODA H
Citation: J. Atzpodien et al., BIOCHEMOTHERAPY OF ADVANCED METASTATIC RENAL-CELL CARCINOMA - RESULTSOF THE COMBINATION OF INTERLEUKIN-2, ALPHA-INTERFERON, 5-FLUOROURACIL, VINBLASTINE, AND 13-CIS-RETINOIC ACID, World journal of urology, 13(3), 1995, pp. 174-177
Authors:
SOSADA M
BERGMANN F
EISERT B
BARTHELS M
POLIWODA H
Citation: M. Sosada et al., ELIMINATION OF AN ACQUIRED FACTOR-VIII-INHIBITOR BY COMPLEX IMMUNOSUPPRESSIVE THERAPY, Thrombosis and haemostasis, 73(6), 1995, pp. 1424-1424
Authors:
MEFFERT M
SCHOMBURG A
HANNINEN EL
MENZEL T
VOCKE S
DALLMANN I
GROSSE J
DUENSING S
BUER J
KIRCHNER H
POLIWODA H
ATZPODIEN J
Citation: M. Meffert et al., IN-VIVO TUMOR-NECROSIS-FACTOR-ALPHA AS INDICATOR OF BIOLOGIC AND CLINICAL-RESPONSE TO LOW-DOSE SC RECOMBINANT INTERLEUKIN-2, Anticancer research, 15(1), 1995, pp. 127-132
Authors:
KRUIT WHJ
GOEY SH
CALABRESI F
LINDEMANN A
STAHEL RA
POLIWODA H
OSTERWALDER B
STOTER G
Citation: Whj. Kruit et al., FINAL REPORT OF A PHASE-II STUDY OF INTERLEUKIN-2 AND INTERFERON ALPHA IN PATIENTS WITH METASTATIC MELANOMA, British Journal of Cancer, 71(6), 1995, pp. 1319-1321
Authors:
LINK H
ARSENIEV L
BAHRE O
BERENSON RJ
BATTMER K
KADAR JG
JACOBS R
CASPER J
KUHL J
SCHUBERT J
DIEDRICH H
POLIWODA H
Citation: H. Link et al., COMBINED TRANSPLANTATION OF ALLOGENEIC BONE-MARROW AND CD34(-CELLS() BLOOD), Blood, 86(7), 1995, pp. 2500-2508
Authors:
BENTER T
PAPADOPOULOS S
PAPE M
MANNS M
POLIWODA H
Citation: T. Benter et al., OPTIMIZATION AND REPRODUCIBILITY OF RANDOM AMPLIFIED POLYMORPHIC DNA IN HUMAN, Analytical biochemistry, 230(1), 1995, pp. 92-100
Authors:
BOKEMEYER C
SCHMOLL HJ
POLIWODA H
Citation: C. Bokemeyer et al., ETOPOSIDE TREATMENT, Deutsche Medizinische Wochenschrift, 119(19), 1994, pp. 707-714
Authors:
MEFFERT M
HANNINEN EL
MENZEL T
SCHOMBURG A
DUENSING S
DALLMANN I
GROSSE J
VOCKE S
BUER J
DECKERT M
HILSE R
KIRCHNER H
POLIWODA H
ATZPODIEN J
Citation: M. Meffert et al., IN-VIVO TIME AND DOSE-DEPENDENCY OF INTERLEUKIN-6 SECRETION IN RESPONSE TO LOW-DOSE SUBCUTANEOUS RECOMBINANT INTERLEUKIN-2, Cancer biotherapy, 9(4), 1994, pp. 307-316
Authors:
ZORN U
DALLMANN I
GROSSE J
KIRCHNER H
POLIWODA H
ATZPODIEN J
Citation: U. Zorn et al., INDUCTION OF CYTOKINES AND CYTOTOXICITY AGAINST TUMOR-CELLS BY NEWCASTLE-DISEASE VIRUS, Cancer biotherapy, 9(3), 1994, pp. 225-235